Why Vertex Pharmaceuticals Stock Is Jumping Today

Why Vertex Pharmaceuticals Stock Is Jumping Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were jumping 8.2% as of 12:01 p.m. ET on Wednesday. The nice gain came after the big biotech announced positive results from a phase 2 proof-of-concept study evaluating VX-147 in treating patients with APOL1-mediated focal segmental glomerulosclerosis (FSGS). FSGS is a kidney disease caused by variants of the APOL1 gene.